Interestingly, bromocriptine (a potent dopamine receptor agonist) has been shown to improve insulin sensitivity in rodent studies [34], whereas exposure of animals to levodopa (a common PD therapeutic) induces an increase in blood glucose levels [35]. The gene discussed is INS; the disease is Parkinson disease.